BCM
NVO

BlueCrest Capital Management’s Novo Nordisk NVO Stock Holding History

BlueCrest Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,838
Closed -$204K – 1312
2018
Q4 		$204K Sell
8,838
-27,232
-75% -$605K 0.01% 645
2018
Q3 		$850K Buy
36,070
+11,522
+47% +$281K 0.02% 510
2018
Q2 		$566K Buy
24,548
+10,594
+76% +$252K 0.01% 764
2018
Q1 		$344K Buy
+13,954
New +$366K 0.01% 969

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BlueCrest Capital Management's NVO Position: Q1 2019 in Review

BlueCrest Capital Management sold out of Novo Nordisk (NVO) in Q1 2019, closing a stake of 8,838 shares — an estimated $204K sold.

BlueCrest Capital Management first reported a position in NVO in Q1 2018 and held it in 4 quarters. The position peaked at $850K in Q3 2018. 580 funds tracked by Wall St. Rank hold NVO as of Q1 2019.

  • BlueCrest Capital Management reported no remaining Novo Nordisk position as of Q1 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 8,838 Novo Nordisk shares in Q1 2019, an estimated $204K.
  • BlueCrest Capital Management first reported a position in Novo Nordisk in Q1 2018 and held it in 4 quarters.
  • BlueCrest Capital Management's Novo Nordisk position peaked at $850K in Q3 2018.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2019.

Based on BlueCrest Capital Management's 13F filing for Q1 2019, filed 15 May 2019.